Multi-Cancer Early Detection Screening Trial Results
A clinical trial for multi-cancer early detection screening showed that annual blood testing significantly reduces stage IV cancer diagnoses and emergency presentations. While the study did not meet its primary endpoint for all cancer types, it demonstrated a 14% reduction in late-stage diagnoses and improved early detection rates.
ANNUAL multi-cancer early detection screening reduces stage IV diagnoses and emergency presentations in randomized clinical trials. Data presented from the landmark randomized controlled trial evaluating blood-based multi-cancer early detection screening demonstrated that adding yearly cell-free DNA blood testing to standard screening protocols significantly alters the clinical timing of cancer identification.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in